227P Peripheral blood lymphocyte counts predict clinical outcomes in patients with hormone receptor-positive HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.

Authors :: Vernieri, C.
Zattarin, E.
Mariani, L.
Menichetti, A.
Leporati, R.
Ligorio, F.
Fuca, G.
Lobefaro, R.
Griguolo, G.
Sirico, M.
Bernocchi, O.
Marra, A.
Agostinetto, E.
Jacobs, F.
di Mauro, P.
Curigliano, G.
Pedersini, R.
Losurdo, A.
Generali, D.
Dieci, M.V.
Source :: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS641-S642. 2p.
Publication Year :: 2022

Subjects :: *METASTATIC breast cancer
*CYCLIN-dependent kinase inhibitors
*LYMPHOCYTE count
*TREATMENT effectiveness
*HORMONES

Full Text Access

Tools